OS Therapies to present 2.5-year overall survival data at ASCO 2026

OS Therapies Incorporated

OS Therapies Incorporated

OSTX

0.00
  • OS Therapies plans to present 2.5-year overall survival data at ASCO 2026 in Chicago, May 29-June 2, 2026.
  • Executives are scheduled for partnering and select investor meetings at the Jefferies Global Healthcare Conference in New York, June 2-4, 2026.
  • Company representatives are set for partnering talks at the BIO International Convention in San Diego, June 22-25, 2026.
  • OS Therapies is due to present data at the MIB Agents Factor Osteosarcoma Conference in Columbus, June 25-27, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OS Therapies Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202605260740NEWSFILECNPR____20260526_298851_1) on May 26, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.